NavigateAI | $25,000,000 | (May 27, 2026)
The Path | $14,300,000 | (May 27, 2026)
Quartermaster | $43,000,000 | (May 27, 2026)
Certified by Founder
Lodge
Ancilia Biosciences
start up
United States
- New York, New York
- 29/08/2024
- Unknown
- $4,200,000
Ancilia is harnessing the natural power of CRISPR to develop a new class of bacterial therapies and products for a range of applications.
- Industry Biotechnology
- Website https://www.anciliabio.com/
- LinkedIn https://www.linkedin.com/company/ancilia/
Qurie GmbH | $2,560,151 | (May 27, 2026)
Clouted | $7,000,000 | (May 27, 2026)
ClearOps | $10,009,454 | (May 27, 2026)
Go Swag | $5,000,000 | (May 27, 2026)
Hardline | $2,000,000 | (May 27, 2026)
Squid | $6,000,000 | (May 27, 2026)
OpenRouter | $113,000,000 | (May 27, 2026)
Hark(1) | $700,000,000 | (May 22, 2026)
Century Health | $5,000,000 | (May 22, 2026)